You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Beta-cell function

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial (Ketogenic diet, food delivery and education, Standard diet, food delivery and education)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Ketogenic diet, food delivery and education
  • Standard diet, food delivery and education
  • (no location specified)
Jun 1, 2023

PreDiabetes Trial (Beef, Poultry)

Not yet recruiting
  • PreDiabetes
  • Beef
  • Poultry
  • (no location specified)
Jul 12, 2022

Type 1 Diabetes Trial in Indianapolis (Acetylated and Butyrylated High Amylose Maize Starch)

Recruiting
  • Type 1 Diabetes
  • Acetylated and Butyrylated High Amylose Maize Starch
  • Indianapolis, Indiana
    Indiana University School of Medicine
Aug 19, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Sep 12, 2022

Type 1 Diabetes Trial in Amsterdam (encapsulated autologous fecal microbiota transplantation)

Recruiting
  • Type 1 Diabetes
  • encapsulated autologous fecal microbiota transplantation
  • Amsterdam, Please Select, Netherlands
    Academisch Medisch Centrum
Apr 5, 2022

Type2 Diabetes, Obesity, Morbid Trial in Hvidovre (Oral Glucose Tolerance Test, Hyperglycemic clamp with infusion of saline,

Completed
  • Type2 Diabetes
  • Obesity, Morbid
  • Oral Glucose Tolerance Test
  • Hyperglycemic clamp with infusion of saline, GLP-1 or GIP
  • Hvidovre, Denmark
    Hvidovre University Hospital
Mar 14, 2022

COVID19, BETA-CELL FUNCTION Trial in Milan (Stimulation test with arginine infusion in order to verify the possible existence of

Recruiting
  • COVID19
  • BETA-CELL FUNCTION
  • Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection
  • Milan, MI, Italy
    Sacco University Hospital
Sep 27, 2021

Type 1 Diabetes Trial in Worcester (Ergocalciferol, Placebo)

Completed
  • Type 1 Diabetes
  • Worcester, Massachusetts
    University of Massachusetts Medical School
Jan 9, 2022

type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

Recruiting
  • type1diabetes
  • +3 more
  • Parma, Pr, Italy
    Azienda Ospedaliero Universitaria di Parma
Dec 20, 2022

Prediabetes, Type 1 Diabetes Trial in Malmö (Gluten free diet, Omega 3 fatty acid, Vitamin D)

Active, not recruiting
  • Prediabetes
  • Type 1 Diabetes
  • Gluten free diet
  • +3 more
  • Malmö, Sweden
    Lund University, Department of Clinical Sciences Malmö
Oct 18, 2021

Type2 Diabetes Trial in Jakarta (Vitamin D 5000 IU, Placebo)

Active, not recruiting
  • Type2 Diabetes Mellitus
  • Vitamin D 5000 IU
  • Placebo
  • Jakarta, DKI Jakarta, Indonesia
    Community Health Centers Kecamatan Mampang Prapatan
Oct 24, 2022

Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Aug 29, 2022

Remission of Type 2 Diabetes in Morbid Obese Patients After

Active, not recruiting
  • Morbid Obesity
  • Type2 Diabetes
  • Laparoscopic Sleeve Gastrectomy
  • (no location specified)
Apr 5, 2022

Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
  • Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
  • Westmead, New South Wales, Australia
  • +5 more
Feb 15, 2023

Healthy Trial in Durham (Active Comparator: Sitagliptin, Placebo Comparator - No Sitagliptin)

Completed
Has Results
  • Healthy
  • Active Comparator: Sitagliptin
  • Placebo Comparator - No Sitagliptin
  • Durham, North Carolina
    Leslie Willis
Apr 6, 2021

Insulin Secretion Trial in Vellore (Ferrous sulphate)

Completed
  • Insulin Secretion
  • Ferrous sulphate
  • Vellore, Tamil Nadu, India
    Christian Medical College
Feb 11, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Glucose Homeostasis in Pseudohypoparathyroidism

Terminated
  • Pseudohypoparathyroidism and Pseudopseudohypoparathyroidism
  • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    May 26, 2021

    Myocardial Infarction, Unstable Angina Pectoris, Diabetes Trial in Stockholm (Sitagliptin)

    Completed
    • Myocardial Infarction
    • +3 more
    • Stockholm, Sweden
    • +1 more
    Feb 11, 2021

    Diabetes, Type 2 Trial in Basel (vildagliptin, )

    Completed
    • Diabetes Mellitus, Type 2
    • Basel, Switzerland
      Novartis Pharmaceuticals
    Dec 11, 2020

    EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type

    Recruiting
    • Type1 Diabetes Mellitus
    • Beta Cell Loss and Immune Function
    • Immune Function with RNAseq
    • Hope, California
    • +3 more
    Jun 1, 2022

    Type 1 Diabetes Trial in Uppsala (Liraglutide, Placebo for liraglutide)

    Completed
    • Type 1 Diabetes
    • Uppsala, Sweden
      Uppsala University Hospital
    Nov 4, 2020

    COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO

    Recruiting
    • Generation of Anti COVID-19 Antibodies in a Fetus, Whose Mother Was Exposed to COVID or Was Vaccinated During Pregnancy
    • no intervention, observation only
    • Bnei Brak, Merkaz, Israel
      Maayanei Hayeshua Medical Center
    Apr 26, 2021

    Type1 Diabetes Trial (BOL-DP-o-05, Placebo)

    Withdrawn
    • Type1 Diabetes Mellitus
    • (no location specified)
    Mar 22, 2021

    Advanced Glycation Endproducts, AGEs, Diet Trial in Maastricht (Diet low or high in advanced glycation endproducts)

    Completed
    • Advanced Glycation Endproducts
    • +5 more
    • Diet low or high in advanced glycation endproducts
    • Maastricht, Limburg, Netherlands
      Maastricht University
    Mar 5, 2021